Annual report [Section 13 and 15(d), not S-K Item 405]

Commitments and Contingencies (Details)

v3.25.1
Commitments and Contingencies (Details)
$ in Thousands
 12 Months Ended
Jul. 19, 2022
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Mar. 31, 2023
site
Other Commitments [Line Items]        
General and administration   $ 37,885 $ 33,442  
Number of sites | site       8
Linebacker License Agreements        
Other Commitments [Line Items]        
Upfront license fee $ 50      
License agreement term (in days) 10 days      
License or royalty net revenue percentage 3.00%      
Minimum royalty $ 250      
General and administration   120 600  
Equivir License Agreement        
Other Commitments [Line Items]        
General and administration   100 400  
BE-Smart License Agreement        
Other Commitments [Line Items]        
General and administration   $ 170 $ 300  
Phase Three | Linebacker License Agreements        
Other Commitments [Line Items]        
Additional payment of fee 900      
New Drug Application | Linebacker License Agreements        
Other Commitments [Line Items]        
Additional payment of fee $ 1,000